{"entity":{"id":"norbert-vey","kind":"person","name":"Norbert Vey","aka":[],"tldr":"Haematologist specialising in leukaemia who has directed Institut Paoli-Calmettes, the Marseille comprehensive cancer centre, since May 2022.","summary":"Norbert Vey is Directeur Général of Institut Paoli-Calmettes (IPC), the Centre de Lutte Contre le Cancer in Marseille, accredited as a Comprehensive Cancer Center by the OECI. He took office on 13 May 2022 for a five-year term following a ministerial decree, succeeding Patrice Viens, who had led the institute since 2007. He is a professor of haematology at Aix-Marseille University and a hospital practitioner specialising in the treatment of leukaemia, and previously directed the institute's haematology department.","asOf":"2026-09-10","links":[{"label":"Source: Institut Paoli-Calmettes appointment announcement","url":"https://www.institutpaolicalmettes.fr/le-pr-norbert-vey-nomme-directeur-general-de-linstitut-paoli-calmettes/"}],"tags":["leadership","clinician-scientist","haematology"],"related":[],"cancers":["aml","all-leukemia"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["institut-paoli-calmettes"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Directeur Général (Director General) of Institut Paoli-Calmettes","institutionId":"institut-paoli-calmettes","specialisms":["Haematology","Leukaemia","Cancer centre management"],"profiles":[{"label":"IPC announcement of appointment","url":"https://www.institutpaolicalmettes.fr/le-pr-norbert-vey-nomme-directeur-general-de-linstitut-paoli-calmettes/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Vey+N%5BAuthor%5D"}],"papers":[{"title":"Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study","journal":"The Lancet Haematology","year":2016,"doi":"10.1016/s2352-3026(15)00247-1"},{"title":"Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia","journal":"New England Journal of Medicine","year":2016,"doi":"10.1056/nejmoa1605085"},{"title":"Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia","journal":"Therapeutic Advances in Hematology","year":2020,"doi":"10.1177/2040620720913010"}],"orcid":"0000-0001-7027-040X"},"route":"/people/norbert-vey/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"}],"institution":[{"id":"institut-paoli-calmettes","kind":"institution","name":"Institut Paoli-Calmettes","route":"/institutions/institut-paoli-calmettes/"}]}}